Financials West Pharmaceutical Services, Inc.

Equities

WST

US9553061055

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 21:00:02 06/09/2024 BST			5-day change	1st Jan Change
297.24 ^USD	-1.02%		-5.23%	-15.59%

08-21	West Pharmaceutical Services Insider Sold Shares Worth $308,700, According to a Recent SEC Filing	MT
08-08	West Pharmaceutical Services Insider Sold Shares Worth $9,364,409, According to a Recent SEC Filing	MT

Projected Income Statement: West Pharmaceutical Services, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	1,840	2,147	2,832	2,887	2,950	2,873	3,089	3,360
Change	-	16.69%	31.89%	1.95%	2.18%	-2.6%	7.5%	8.77%
EBITDA ¹	399.8	526.1	884.7	882.6	827.9	702.3	860.7	981.5
Change	-	31.59%	68.16%	-0.24%	-6.2%	-15.17%	22.55%	14.04%
EBIT ¹	296.4	417	762.4	762	690.6	546.8	693.8	803.6
Change	-	40.69%	82.83%	-0.05%	-9.37%	-20.83%	26.89%	15.82%
Interest Paid ¹	-4.7	-6.8	-7.2	-2.8	19	-10	-8.65	-8.55
Earnings before Tax (EBT) ¹	291.8	401.3	748.9	679.9	698	550.4	717.8	819.1
Change	-	37.53%	86.62%	-9.21%	2.66%	-21.14%	30.41%	14.11%
Net income ¹	241.7	346.2	661.8	585.9	593.4	484.3	599.1	703.1
Change	-	43.24%	91.16%	-11.47%	1.28%	-18.39%	23.7%	17.37%
Announcement Date	13/02/20	18/02/21	17/02/22	16/02/23	15/02/24	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2
Net sales ¹	456.1	470.6	491.5	527.2	548	580.2	670.7	723.6	706.5	730.8	720	771.3	686.9	708.7	716.6	753.8	747.4	732	695.4	702.1	709.2	764.9	736.2	762.4	750.6	805.7	788.6	817.3
Change	-	3.18%	4.44%	7.26%	3.95%	5.88%	15.6%	7.89%	-2.36%	3.44%	-1.48%	7.12%	-10.94%	3.17%	1.11%	5.19%	-0.85%	-2.06%	-5%	0.96%	1.02%	7.85%	-3.76%	3.57%	-1.56%	7.35%	-2.13%	3.65%
EBITDA ¹	95.4	99.4	114	132	132.3	147.6	208.3	240	212.8	223.6	219.5	257.1	216.2	189.8	196.5	215.5	216.5	195.8	158.6	165.3	172.1	205.6	186.8	206.1	195.7	215.4	205.4	220.4
Change	-	4.19%	14.69%	15.79%	0.23%	11.56%	41.12%	15.22%	-11.33%	5.08%	-1.83%	17.13%	-15.91%	-12.21%	3.53%	9.67%	0.46%	-9.56%	-19%	4.22%	4.14%	19.45%	-9.14%	10.29%	-5.01%	10.06%	-4.66%	7.3%
EBIT ¹	70.1	73.1	88	106	103.9	119.1	179.2	211.2	182.8	189.2	189.9	227	186.4	158.7	164.9	185	180.8	159.9	123	126.4	132.4	165.3	146.5	165.6	155.2	174.4	159.4	174.1
Change	-	4.28%	20.38%	20.45%	-1.98%	14.63%	50.46%	17.86%	-13.45%	3.5%	0.37%	19.54%	-17.89%	-14.86%	3.91%	12.19%	-2.27%	-11.56%	-23.08%	2.76%	4.75%	24.82%	-11.35%	13.01%	-6.29%	12.4%	-8.57%	9.19%
Charge d'intérêts	-1.1	-0.8	-1.2	-1.8	-1.9	-1.9	-1.8	-1.7	-1.4	-2.3	-1.9	-1.4	-0.7	1.2	2.6	2.3	5.9	-	-	-	-	-0.8	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	64.9	77.4	86.5	102	97.7	115.1	174.9	211	181.1	181.9	187.8	227.2	136.2	128.7	157.9	184.9	187	168.2	127.4	128.7	131.9	166.6	148.7	167.8	157.4	176.5	159.6	173.8
Change	-	19.26%	11.76%	17.92%	-4.22%	17.81%	51.95%	20.64%	-14.17%	0.44%	3.24%	20.98%	-40.05%	-5.51%	22.69%	17.1%	1.14%	-10.05%	-24.26%	1.02%	2.51%	26.25%	-10.72%	12.83%	-6.2%	12.12%	-9.54%	8.85%
Net income ¹	56.3	63.9	74.3	91.2	82.3	98.4	151.2	187.3	175.6	147.7	173.8	188.5	120.6	103	140	155.1	161.3	137	115.3	111.3	107	134.8	125.9	144.7	135.7	146.9	-	-
Change	-	13.5%	16.28%	22.75%	-9.76%	19.56%	53.66%	23.88%	-6.25%	-15.89%	17.67%	8.46%	-36.02%	-14.59%	35.92%	10.79%	4%	-15.07%	-15.84%	-3.47%	-3.89%	26%	-6.59%	14.93%	-6.22%	8.25%	-100%	-
Announcement Date	24/10/19	13/02/20	23/04/20	23/07/20	22/10/20	18/02/21	29/04/21	29/07/21	28/10/21	17/02/22	28/04/22	28/07/22	27/10/22	16/02/23	27/04/23	27/07/23	26/10/23	15/02/24	25/04/24	25/07/24	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: West Pharmaceutical Services, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	-	-	-685	-647	-573	-829	-1,112
Change	-	-	-	-	-194.45%	-188.55%	-244.68%	-234.14%
Announcement Date	13/02/20	18/02/21	17/02/22	16/02/23	15/02/24	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: West Pharmaceutical Services, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	126.4	174.4	253.4	284.6	362	370.2	310.4	314.4
Change	-	37.97%	45.3%	12.31%	27.2%	2.27%	-16.15%	1.28%
Free Cash Flow (FCF) ¹	240.8	298.1	330.6	439.4	414.5	212.9	468.2	613.6
Change	-	23.8%	10.9%	32.91%	-5.67%	-48.64%	119.93%	31.05%
Announcement Date	13/02/20	18/02/21	17/02/22	16/02/23	15/02/24	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: West Pharmaceutical Services, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	21.73%	24.51%	31.24%	30.57%	28.07%	24.44%	27.86%	29.21%
EBIT Margin (%)	16.11%	19.42%	26.92%	26.4%	23.41%	19.03%	22.46%	23.92%
EBT Margin (%)	15.86%	18.69%	26.45%	23.55%	23.66%	19.16%	23.24%	24.38%
Net margin (%)	13.14%	16.13%	23.37%	20.3%	20.12%	16.86%	19.39%	20.93%
FCF margin (%)	13.09%	13.89%	11.68%	15.22%	14.05%	7.41%	15.16%	18.26%
FCF / Net Income (%)	99.63%	86.11%	49.95%	75%	69.85%	43.96%	78.16%	87.27%
Profitability
ROA	11.19%	13.48%	21.67%	18.76%	16.35%	12.32%	14.66%	15.35%
ROE	16.28%	20.2%	31.59%	25.89%	21.88%	16.44%	19.21%	19.97%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	6.87%	8.12%	8.95%	9.86%	12.27%	12.88%	10.05%	9.36%
CAPEX / EBITDA (%)	31.62%	33.15%	28.64%	32.25%	43.73%	52.72%	36.07%	32.03%
CAPEX / FCF (%)	52.49%	58.5%	76.65%	64.77%	87.33%	173.89%	66.29%	51.24%
Items per share
Cash flow per share ¹	4.87	6.234	7.654	9.551	10.31	8.363	9.873	10.18
Change	-	28%	22.79%	24.79%	7.96%	-18.9%	18.05%	3.09%
Dividend per Share ¹	0.61	0.66	0.69	0.74	0.78	0.7903	0.8769	1.07
Change	-	8.2%	4.55%	7.25%	5.41%	1.32%	10.96%	22.02%
Book Value Per Share ¹	21.23	25.05	31.47	36.23	39.2	37.06	39.15	41.79
Change	-	18.01%	25.63%	15.12%	8.18%	-5.44%	5.64%	6.73%
EPS ¹	3.21	4.57	8.67	7.73	7.88	6.501	7.892	9.052
Change	-	42.37%	89.72%	-10.84%	1.94%	-17.5%	21.4%	14.7%
Nbr of stocks (in thousands)	73,991	73,927	74,080	74,033	73,990	72,542	72,542	72,542
Announcement Date	13/02/20	18/02/21	17/02/22	16/02/23	15/02/24	-	-	-